Dynamic and Static Splinting as a Treatment for Plantar Faciiopathy
This study is currently recruiting participants.
Verified April 2012 by Dynasplint Systems, Inc.
Sponsor:
Dynasplint Systems, Inc.
Information provided by (Responsible Party):
Dynasplint Systems, Inc.
ClinicalTrials.gov Identifier:
NCT01588730
First received: July 14, 2011
Last updated: April 27, 2012
Last verified: April 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to compare the Ankle Dorsiflexion Dynasplint System (DS) to static night splint for the reduction of pain from Plantar Fasciitis (Fasciopathy).
| Condition | Intervention | Phase |
|---|---|---|
|
Plantar Fasciitis Plantar Fasciopathy |
Device: Ankle Dorsiflexion Dynasplint Procedure: Commercially Available Static Night splint |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Dynamic and Static Splinting as a Treatment for Plantar Faciiopathy |
Further study details as provided by Dynasplint Systems, Inc.:
Primary Outcome Measures:
- FFI score [ Time Frame: 16 weeks ] [ Designated as safety issue: No ]The primary outcome measure will be difference between the pretreatment and two month cumulative Foot Function Index (PS-FFI) score
Secondary Outcome Measures:
- Pain subscale and SROM questionnaire [ Time Frame: 2, 4 and 12 months ] [ Designated as safety issue: No ]
Secondary outcome measures will include two month, four month, and twelve month overall heel pain reduction measured by the responses to the following questionnaires:
- Pain subscale of the validated Foot Function Index (PS-FFI)
- A patient-relevant outcome measures (SROM) questionnaire that included generic and condition -specific outcome measures related to pain, function, and satisfaction with the treatment outcome.
| Estimated Enrollment: | 120 |
| Study Start Date: | June 2011 |
| Estimated Study Completion Date: | June 2012 |
| Estimated Primary Completion Date: | June 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Dynasplint
Dynamic Splinting utilizes the protocols of Low-Load, Prolonged-Duration Stretch (LLPS) with calibrated, adjustable tension to increase the Total End Range Time (TERT) to reduce contracture. This unit is worn at night while sleeping (6-8 hours).
|
Device: Ankle Dorsiflexion Dynasplint
Dynamic Splinting utilizes the protocols of Low-Load, Prolonged-Duration Stretch (LLPS) with calibrated, adjustable tension to increase the Total End Range Time (TERT) to reduce contracture. This unit is worn at night while sleeping (6-8 hours) and, this does not affect activities of daily living
|
|
Active Comparator: Static Splint
The control group will be treated with a static splint for a minimum of 6 4 hours each night while sleeping with the end goal of 6-8 hours.
|
Procedure: Commercially Available Static Night splint
A commericially avilable static night splint will be worn for 4-6 hours during rest.
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- All patients will have had a history of at least 3 consecutive months of plantar heel pain well-localized to the plantar fascia.
- All patients will have failed an initial treatment of non-weight bearing plantar and Achilles stretching.
- Diagnosis will be confirmed by physical examination by a single physician (JPF) with a typical point of maximum tenderness over the medial tubercle of the calcaneus
Exclusion Criteria:
- rheumatoid arthritis
- local infection
- pregnancy
- patients with tumors
- unresolved fractures
- severe peripheral vascular disease
- history of prior plantar fascia surgery
- history of plantar fascia rupture
- age <18 years
- recent ( within 6 weeks) steroid injection
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01588730
Contacts
| Contact: John Furia, MD | 570-524-4446 | jfuria@sunortho.com |
Locations
| United States, Pennsylvania | |
| SUN Orthopaedic Group Inc | Recruiting |
| Lewisburg, Pennsylvania, United States, 17837 | |
| Contact: John Furia, MD 570-524-4446 furia@sunortho.com | |
Sponsors and Collaborators
Dynasplint Systems, Inc.
Investigators
| Principal Investigator: | John Furia, MD | SUN Orthopaedic Group Inc |
More Information
Publications:
Furia JP, Rompe JD .Extracorporeal shock wave therapy in the treatment of chronic plantar fasciitis and Achilles tendinopathy.Curr Opin Orthop 2007;18:102-111
| Responsible Party: | Dynasplint Systems, Inc. |
| ClinicalTrials.gov Identifier: | NCT01588730 History of Changes |
| Other Study ID Numbers: | Dyna-PF 2011 |
| Study First Received: | July 14, 2011 |
| Last Updated: | April 27, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Dynasplint Systems, Inc.:
|
PF Dynasplint ADFD |
AFD Plantar Fasciitis plantar Fasciopathy |
Additional relevant MeSH terms:
|
Fasciitis Fasciitis, Plantar Musculoskeletal Diseases Foot Diseases |
ClinicalTrials.gov processed this record on May 19, 2013